2017_SBRT_Course Book
Patient presentation
• 65 year old female • Performance status 90% • Comorbidities: • No relevant until diagnosis of cancer • Paraneoplastic syndroms: • Anemia • Depression after diagnosis of cancer
07.09.17 ESTRO SBRT COURSE 2017 - Matthias Guckenberger
3
/
Initial staging & histopathology
Primary
Hilar LN Adrenal
Ø NSCLC cT2 cN1 cM1 (adrenal), Adeno Carcinoma Ø Synchronous oligo-metastatic stage IV NSCLC Ø EGFR, BRAF, KRAS, ERBB2, ALK, ROS1 negative 08/2015
07.09.17 ESTRO SBRT COURSE 2017 - Matthias Guckenberger
4
/
Made with FlippingBook Annual report